Characterization of novel hyaluronic acid matrix systems for vaginal administration of metronidazole

Authors

  • P. Rodríguez-Belenguer,

    Corresponding author
    1. Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Valencia, -Burjassot, Valencia, Spain
    2. Institute of Molecular Recognition and Technological Development (IDM), Polytechnic University of Valencia, Valencia, Spain
    Search for more papers by this author
  • A. Nácher,

    1. Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Valencia, -Burjassot, Valencia, Spain
    2. Institute of Molecular Recognition and Technological Development (IDM), Polytechnic University of Valencia, Valencia, Spain
    Search for more papers by this author
  • M. J. Hernández,

    1. Department of Earth Physics and Thermodinamics, Faculty of Physics, University of Valencia, -Burjassot, Valencia, Spain
    Search for more papers by this author
  • O. Díez-Sales

    1. Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Valencia, -Burjassot, Valencia, Spain
    2. Institute of Molecular Recognition and Technological Development (IDM), Polytechnic University of Valencia, Valencia, Spain
    Search for more papers by this author

ABSTRACT

Polymers such as Hyaluronic acid (HA), Polyethylene glycol-400 (PEG-400) and Xanthan Gum (XG) are promising in drug delivery applicationsbecause of their biomedical and pharmaceutical potential applications. In HA 2%-PEG 400 systems, the effect of pH and PEG-400 concentration were evaluated. The viscosity of HA-PEG 400 formulations slightly increased with PEG-400 concentration. Viscoelastic properties and shear thinning character was strongly dependent on pH. Structured systems were obtained at pH 3, with an increase of several orders of magnitude in zero-shear viscosity values. When XG 1% structured system is added on HA (0, 0.5, and 2%) and PEG-400 5%, a sharp increase of viscosity can be observed, obtaining a gel-like behaviour for HA 0.5%-XG 1%-PEG 400 5% formulation. Finally, metronidazole release profiles in HA 2% formulations with different PEG-400 concentrations at pH 4.5 were studied. At least 90% of metronidazole was releasedat 24 h. However, the addition of XG 1% to the HA (0.5 and 2%)-PEG 400 5% systems delayed the drug release. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015, 132, 41313.

Ancillary